Skip to content
HomeLatest newsGlassdoor names Johnson & Johnson’s Alex Gorsky a 2018 top CEO
FINAL LEDE- A Look Back on Our Work in 2019- Alex gorsky dyir digital year in review

Glassdoor names Johnson & Johnson’s Alex Gorsky a 2018 top CEO

The Chairman and CEO has now appeared on the Glassdoor list for five years running—all thanks to his employees.

How many people can say they love their boss? At Johnson & Johnson, a whole lot of employees can—and do.

For the fifth year in a row, Alex Gorsky, Chairman of the Board and Chief Executive Officer of Johnson & Johnson, has been named to Glassdoor’s Employees’ Choice Awards list of Top CEOs.

Glassdoor, one of the world’s largest jobs and recruiting sites, compiles its annual list of best CEOs throughout North America and parts of Europe based solely on employee reviews submitted through its platform—and 95% of staffers who reviewed Johnson & Johnson for the 2018 rankings said they approved of Gorsky’s leadership.

To help put that into perspective, 770,000 companies were reviewed, and the average CEO approval rating came in at 69%.

As the seventh Chairman and CEO since the company went public in 1944, Gorsky’s leadership has personified the values of Johnson & Johnson’s Credo—the company’s guiding mission statement, which prioritizes the needs of patients and employees alike—and has helped Johnson & Johnson solidify its position as the largest and most broadly based healthcare company in the world.

And this isn’t the only accolade the company has recently garnered under Gorsky’s direction: Johnson & Johnson also took the #1 spot on the 2018 DiversityInc Top 50 Companies for Diversity list, and was named a 2018 Fortune World’s Most Admired Company.

Congratulations to Gorsky on the recognition of his exceptional leadership.


More from Johnson & Johnson

Meet the medical engineer behind the innovative heart pump that revolutionized cardiac health

Drawing on his fascination with airplane technology, Thorsten Siess, Ph.D., came up with an idea that became the Impella heart pump. Now, 25 years since it entered the market, this groundbreaking device has helped more than 330,000 patients recover from heart injuries.

What you need to know about Johnson & Johnson’s 2024 third quarter earnings

Check out this infographic breakdown of the company’s third quarter performance, with highlights from its Innovative Medicine and MedTech businesses.

What is a rheumatic disease?

More than 200 conditions are classified as rheumatic diseases, including rheumatoid arthritis, lupus and Sjögren’s disease. They tend to affect the joints and connective tissues, causing pain and swelling and impacting quality of life. Here’s what a doctor wants you to know about the different types, symptoms and risk factors—and how Johnson & Johnson is innovating new treatments.